$JBLU

Hurley Ursula L sold $445K of JBLU

Hurley Ursula L (Chief Financial Officer) sold 77,253 shares of JETBLUE AIRWAYS CORP (JBLU) at an average of $5.76 ($5.75–$6.00, $0.44M total) across 2 trades on 2026-07-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hurley Ursula L
Published Aug 3, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 3, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$JBLU
Neutral
high confidence
Mentioned
$JBLU
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JBLUNeutralLow
01

Why it matters

The disclosed open-market sale is pre-arranged under Rule 10b5-1, which generally limits the signal strength for future fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 designation makes it more of a routine disclosure than a catalyst.

03

What to watch

The article provides only the sale details; it does not include any offsetting purchases, changes in compensation, or broader insider activity trends.

Relevance 3/10Novelty 3/10Timing: filed Aug 3, 2026 after-hours

Background

The article is an SEC Form 4 insider transaction disclosure for JetBlue Airways Corp, reported by the CFO.

Company-level read

Ticker impact

$JBLUNeutralHigh confidence
Context

JetBlue CFO Hurley Ursula L sold about 77,253 shares in open-market transactions totaling $444,949 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicit pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary sales.

Market effects

No direct sector read-through; this is company-specific insider activity without operational or guidance content.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with internal risk management or diversification needs, which some traders may interpret as caution.

Key entities

  • JetBlue Airways Corp

    Subject of the Form 4 insider transaction disclosure.

  • Hurley Ursula L

    Chief Financial Officer who executed the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JBLUMedAI 8/10

JetBlue raises third-quarter fuel price forecast

JetBlue Airways raised its third-quarter fuel price forecast to $3.96 per gallon, up from $3.49, due to elevated prices from the Iran war. The airline also reported higher operating costs from weather and air traffic disruptions. Despite these, it expects revenue per available seat mile to rise 17-20%, up from prior guidance of 12.5-16.5%. Shares were down 1% in premarket trading.

$JBLUHighAI 8/10

Why is JetBlue Airways stock climbing today?

JetBlue Airways (JBLU) stock rose 0.7% in pre-market trading after revising its Q3 2026 revenue guidance upwards to 17-20% YoY growth, up from 12.5-16.5%. The company also tightened its capacity outlook but increased its cost forecast due to weather disruptions. The move reflects company-specific optimism rather than broader market trends.

$JBLUHigh

JetBlue stock falls 3% despite raising revenue outlook

JetBlue (JBLU) shares fell 3% after raising its Q3 2026 revenue outlook to 17.0%-20.0% YoY growth, up from 12.5%-16.5%. Higher costs, including fuel and operational disruptions, offset the improved outlook, with CASM ex-Fuel expected to rise 6.0%-8.0% YoY. The airline also reduced its capacity growth outlook and lowered capital expenditures guidance to $275M.

$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.